UPDATE 1-U.S. FDA panel: Novo Nordisk's liraglutide safe, effective for obesity

WASHINGTON, Sept 11 (Reuters) - Novo Nordisk's drug liraglutide is safe and effective enough to warrant approval for use in chronically obese patients with at least one weight-related health issue, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.